BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tzoulis C, Engelsen BA, Telstad W, Aasly J, Zeviani M, Winterthun S, Ferrari G, Aarseth JH, Bindoff LA. The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain 2006;129:1685-92. [PMID: 16638794 DOI: 10.1093/brain/awl097] [Cited by in Crossref: 216] [Cited by in F6Publishing: 195] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 Saneto RP. Alpers-Huttenlocher syndrome: the role of a multidisciplinary health care team. J Multidiscip Healthc 2016;9:323-33. [PMID: 27555780 DOI: 10.2147/JMDH.S84900] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Milone M, Massie R. Polymerase Gamma 1 Mutations: Clinical Correlations. The Neurologist 2010;16:84-91. [DOI: 10.1097/nrl.0b013e3181c78a89] [Cited by in Crossref: 68] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
3 Kirschenbaum D, Hedberg-oldfors C, Oldfors A, Scherer E, Budka H. Distinctive cerebral neuropathology in an adult case of sensory ataxic neuropathy with dysarthria and ophthalmoplegia (SANDO) syndrome. Neuropathol Appl Neurobiol 2018;44:639-42. [DOI: 10.1111/nan.12429] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
4 Vogel AP, Rommel N, Oettinger A, Horger M, Krumm P, Kraus EM, Schöls L, Synofzik M. Speech and swallowing abnormalities in adults with POLG associated ataxia (POLG-A). Mitochondrion 2017;37:1-7. [PMID: 28634151 DOI: 10.1016/j.mito.2017.06.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
5 Chinnery PF, Zeviani M. 155th ENMC workshop: polymerase gamma and disorders of mitochondrial DNA synthesis, 21-23 September 2007, Naarden, The Netherlands. Neuromuscul Disord 2008;18:259-67. [PMID: 18160290 DOI: 10.1016/j.nmd.2007.11.005] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 3.3] [Reference Citation Analysis]
6 Prüss H, Holtkamp M. Ketamine successfully terminates malignant status epilepticus. Epilepsy Research 2008;82:219-22. [DOI: 10.1016/j.eplepsyres.2008.08.005] [Cited by in Crossref: 78] [Cited by in F6Publishing: 63] [Article Influence: 5.6] [Reference Citation Analysis]
7 Moustris A, Edwards MJ, Bhatia KP. Movement disorders and mitochondrial disease. Handb Clin Neurol 2011;100:173-92. [PMID: 21496577 DOI: 10.1016/B978-0-444-52014-2.00010-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
8 Honzik T, Tesarova M, Magner M, Mayr J, Jesina P, Vesela K, Wenchich L, Szentivanyi K, Hansikova H, Sperl W, Zeman J. Neonatal onset of mitochondrial disorders in 129 patients: clinical and laboratory characteristics and a new approach to diagnosis. J Inherit Metab Dis 2012;35:749-59. [DOI: 10.1007/s10545-011-9440-3] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 4.6] [Reference Citation Analysis]
9 Granata T. Metabolic and degenerative disorders. Epilepsy. Elsevier; 2012. pp. 485-511. [DOI: 10.1016/b978-0-444-52899-5.00045-9] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
10 Synofzik M, Németh AH. Recessive ataxias. The Cerebellum: Disorders and Treatment. Elsevier; 2018. pp. 73-89. [DOI: 10.1016/b978-0-444-64189-2.00005-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
11 Steele HE, Horvath R, Lyon JJ, Chinnery PF. Monitoring clinical progression with mitochondrial disease biomarkers. Brain. 2017;140:2530-2540. [PMID: 28969370 DOI: 10.1093/brain/awx168] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
12 Parker D, Sanders EJ, Burghardt KJ. Pharmacogenetics of antiepileptic drugs: A brief review. Ment Health Clin 2016;6:28-34. [PMID: 29955444 DOI: 10.9740/mhc.2016.01.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Tzoulis C, Tran GT, Schwarzlmüller T, Specht K, Haugarvoll K, Balafkan N, Lilleng PK, Miletic H, Biermann M, Bindoff LA. Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations. Brain 2013;136:2393-404. [PMID: 23625061 DOI: 10.1093/brain/awt103] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 6.7] [Reference Citation Analysis]
14 Degardin A, Dobbelaere D, Vuillaume I, Defoort-dhellemmes S, Hurtevent J, Sablonnière B, Destée A, Defebvre L, Devos D. Spinocerebellar Ataxia: A Rational Approach to Aetiological Diagnosis. Cerebellum 2012;11:289-99. [DOI: 10.1007/s12311-011-0310-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
15 Suomalainen A, Isohanni P. Mitochondrial DNA depletion syndromes--many genes, common mechanisms. Neuromuscul Disord 2010;20:429-37. [PMID: 20444604 DOI: 10.1016/j.nmd.2010.03.017] [Cited by in Crossref: 144] [Cited by in F6Publishing: 127] [Article Influence: 12.0] [Reference Citation Analysis]
16 Caietta E, Cano A, Halbert C, Hugonenq C, Mancini J, Milh M, Lépine A, Villeneuve N, Chaussenot A, Paquis-Flucklinger V, Chabrol B. [Epilepsy and mitochondrial diseases: retrospective study on 53 epileptic children]. Arch Pediatr 2012;19:794-802. [PMID: 22789745 DOI: 10.1016/j.arcped.2012.05.004] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Rahman S, Copeland WC. POLG-related disorders and their neurological manifestations. Nat Rev Neurol 2019;15:40-52. [PMID: 30451971 DOI: 10.1038/s41582-018-0101-0] [Cited by in Crossref: 94] [Cited by in F6Publishing: 73] [Article Influence: 47.0] [Reference Citation Analysis]
18 Müller-Höcker J, Horvath R, Schäfer S, Hessel H, Müller-Felber W, Kühr J, Copeland WC, Seibel P. Mitochondrial DNA depletion and fatal infantile hepatic failure due to mutations in the mitochondrial polymerase γ (POLG) gene: a combined morphological/enzyme histochemical and immunocytochemical/biochemical and molecular genetic study. J Cell Mol Med 2011;15:445-56. [PMID: 19538466 DOI: 10.1111/j.1582-4934.2009.00819.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
19 Whittaker RG, Devine HE, Gorman GS, Schaefer AM, Horvath R, Ng Y, Nesbitt V, Lax NZ, McFarland R, Cunningham MO, Taylor RW, Turnbull DM. Epilepsy in adults with mitochondrial disease: A cohort study. Ann Neurol 2015;78:949-57. [PMID: 26381753 DOI: 10.1002/ana.24525] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 6.1] [Reference Citation Analysis]
20 Chan SS, Naviaux RK, Basinger AA, Casas KA, Copeland WC. De novo mutation in POLG leads to haplotype insufficiency and Alpers syndrome. Mitochondrion 2009;9:340-5. [PMID: 19501198 DOI: 10.1016/j.mito.2009.05.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
21 Finsterer J. Inherited Mitochondrial Disorders. In: Scatena R, Bottoni P, Giardina B, editors. Advances in Mitochondrial Medicine. Dordrecht: Springer Netherlands; 2012. pp. 187-213. [DOI: 10.1007/978-94-007-2869-1_8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
22 Miguel R, Gago MF, Martins J, Barros P, Vale J, Rosas MJ. POLG1-related levodopa-responsive parkinsonism. Clinical Neurology and Neurosurgery 2014;126:47-54. [DOI: 10.1016/j.clineuro.2014.08.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
23 Neeve VC, Samuels DC, Bindoff LA, van den Bosch B, Van Goethem G, Smeets H, Lombès A, Jardel C, Hirano M, Dimauro S, De Vries M, Smeitink J, Smits BW, de Coo IF, Saft C, Klopstock T, Keiling BC, Czermin B, Abicht A, Lochmüller H, Hudson G, Gorman GG, Turnbull DM, Taylor RW, Holinski-Feder E, Chinnery PF, Horvath R. What is influencing the phenotype of the common homozygous polymerase-γ mutation p.Ala467Thr? Brain 2012;135:3614-26. [PMID: 23250882 DOI: 10.1093/brain/aws298] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
24 Craig AK, de Menezes MS, Saneto RP. Dravet syndrome: patients with co-morbid SCN1A gene mutations and mitochondrial electron transport chain defects. Seizure 2012;21:17-20. [PMID: 21906962 DOI: 10.1016/j.seizure.2011.08.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
25 Spinazzola A. Mitochondrial DNA mutations and depletion in pediatric medicine. Seminars in Fetal and Neonatal Medicine 2011;16:190-6. [DOI: 10.1016/j.siny.2011.04.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
26 El Sabbagh S, Lebre AS, Bahi-Buisson N, Delonlay P, Soufflet C, Boddaert N, Rio M, Rötig A, Dulac O, Munnich A, Desguerre I. Epileptic phenotypes in children with respiratory chain disorders. Epilepsia 2010;51:1225-35. [PMID: 20196775 DOI: 10.1111/j.1528-1167.2009.02504.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 5.9] [Reference Citation Analysis]
27 Fogel BL, Perlman S. Clinical features and molecular genetics of autosomal recessive cerebellar ataxias. The Lancet Neurology 2007;6:245-57. [DOI: 10.1016/s1474-4422(07)70054-6] [Cited by in Crossref: 194] [Cited by in F6Publishing: 75] [Article Influence: 12.9] [Reference Citation Analysis]
28 Konno T, Broderick DF, Tacik P, Caviness JN, Wszolek ZK. Hypertrophic olivary degeneration: A clinico-radiologic study. Parkinsonism Relat Disord 2016;28:36-40. [PMID: 27132500 DOI: 10.1016/j.parkreldis.2016.04.008] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
29 Weiss MD, Saneto RP. Sensory ataxic neuropathy with dysarthria and ophthalmoparesis (SANDO) in late life due to compound heterozygous POLG mutations. Muscle Nerve 2010;41:882-5. [PMID: 20513108 DOI: 10.1002/mus.21636] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
30 Nanau RM, Neuman MG. Adverse drug reactions induced by valproic acid. Clin Biochem. 2013;46:1323-1338. [PMID: 23792104 DOI: 10.1016/j.clinbiochem.2013.06.012] [Cited by in Crossref: 151] [Cited by in F6Publishing: 125] [Article Influence: 16.8] [Reference Citation Analysis]
31 Franciotta D, Kwan P, Perucca E. Genetic basis for idiosyncratic reactions to antiepileptic drugs. Current Opinion in Neurology 2009;22:144-9. [DOI: 10.1097/wco.0b013e328328f276] [Cited by in Crossref: 37] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
32 Menezes MP, Ouvrier RA. Peripheral neuropathy associated with mitochondrial disease in children. Dev Med Child Neurol 2012;54:407-14. [PMID: 22435634 DOI: 10.1111/j.1469-8749.2012.04271.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
33 Gorman GS, Chinnery PF, DiMauro S, Hirano M, Koga Y, McFarland R, Suomalainen A, Thorburn DR, Zeviani M, Turnbull DM. Mitochondrial diseases. Nat Rev Dis Primers 2016;2:16080. [PMID: 27775730 DOI: 10.1038/nrdp.2016.80] [Cited by in Crossref: 475] [Cited by in F6Publishing: 411] [Article Influence: 79.2] [Reference Citation Analysis]
34 Finsterer J. Cognitive decline as a manifestation of mitochondrial disorders (mitochondrial dementia). Journal of the Neurological Sciences 2008;272:20-33. [DOI: 10.1016/j.jns.2008.05.011] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
35 Habek M, Barun B, Adamec I, Mitrović Z, Ozretić D, Brinar VV. Early-onset ataxia with progressive external ophthalmoplegia associated with POLG mutation: autosomal recessive mitochondrial ataxic syndrome or SANDO? Neurologist 2012;18:287-9. [PMID: 22931735 DOI: 10.1097/NRL.0b013e318266f5a6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
36 Tzoulis C, Henriksen E, Miletic H, Bindoff LA. No evidence of ischemia in stroke-like lesions of mitochondrial POLG encephalopathy. Mitochondrion 2017;32:10-5. [DOI: 10.1016/j.mito.2016.11.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
37 Caminero A, Manso-Calderón R. Links between headaches and epilepsy: current knowledge and terminology. Neurologia 2014;29:453-63. [PMID: 22217520 DOI: 10.1016/j.nrl.2011.10.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
38 Tzoulis C, Bindoff LA. Acute mitochondrial encephalopathy reflects neuronal energy failure irrespective of which genome the genetic defect affects. Brain 2012;135:3627-34. [PMID: 23065482 DOI: 10.1093/brain/aws223] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
39 Gopan A, Sarma MS. Mitochondrial hepatopathy: Respiratory chain disorders- ‘breathing in and out of the liver’. World J Hepatol 2021; 13(11): 1707-1726 [PMID: 34904040 DOI: 10.4254/wjh.v13.i11.1707] [Reference Citation Analysis]
40 Bekheirnia MR, Zhang W, Eble T, Willis A, Shaibani A, Wong LC, Scaglia F, Dhar SU. POLG mutation in a patient with cataracts, early-onset distal muscle weakness and atrophy, ovarian dysgenesis and 3-methylglutaconic aciduria. Gene 2012;499:209-12. [DOI: 10.1016/j.gene.2012.02.034] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
41 Flønes IH, Tzoulis C. Movement disorders in mitochondrial disease: a clinicopathological correlation. Current Opinion in Neurology 2018;31:472-83. [DOI: 10.1097/wco.0000000000000583] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
42 Baruffini E, Lodi T, Dallabona C, Puglisi A, Zeviani M, Ferrero I. Genetic and chemical rescue of the Saccharomyces cerevisiae phenotype induced by mitochondrial DNA polymerase mutations associated with progressive external ophthalmoplegia in humans. Hum Mol Genet 2006;15:2846-55. [PMID: 16940310 DOI: 10.1093/hmg/ddl219] [Cited by in Crossref: 62] [Cited by in F6Publishing: 62] [Article Influence: 3.9] [Reference Citation Analysis]
43 Hynynen J, Pokka T, Komulainen-Ebrahim J, Myllynen P, Kärppä M, Pylvänen L, Kälviäinen R, Sokka A, Jyrkilä A, Lähdetie J, Haataja L, Mäkitalo A, Ylikotila P, Eriksson K, Haapala P, Ansakorpi H, Hinttala R, Vieira P, Majamaa K, Rantala H, Uusimaa J. Variants p.Q1236H and p.E1143G in mitochondrial DNA polymerase gamma POLG1 are not associated with increased risk for valproate-induced hepatotoxicity or pancreatic toxicity: A retrospective cohort study of patients with epilepsy. Epilepsia 2018;59:2125-36. [PMID: 30255931 DOI: 10.1111/epi.14568] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Filograna R, Mennuni M, Alsina D, Larsson NG. Mitochondrial DNA copy number in human disease: the more the better? FEBS Lett 2021;595:976-1002. [PMID: 33314045 DOI: 10.1002/1873-3468.14021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
45 Schaller A, Hahn D, Jackson CB, Kern I, Chardot C, Belli DC, Gallati S, Nuoffer JM. Molecular and biochemical characterisation of a novel mutation in POLG associated with Alpers syndrome. BMC Neurol 2011;11:4. [PMID: 21235791 DOI: 10.1186/1471-2377-11-4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
46 Gwathmey KG. Sensory neuronopathies: Sensory Neuronopathies. Muscle Nerve 2016;53:8-19. [DOI: 10.1002/mus.24943] [Cited by in Crossref: 46] [Cited by in F6Publishing: 31] [Article Influence: 6.6] [Reference Citation Analysis]
47 McKiernan P, Ball S, Santra S, Foster K, Fratter C, Poulton J, Craig K, McFarland R, Rahman S, Hargreaves I, Gupte G, Sharif K, Taylor RW. Incidence of Primary Mitochondrial Disease in Children Younger Than 2 Years Presenting With Acute Liver Failure. J Pediatr Gastroenterol Nutr 2016;63:592-7. [PMID: 27482763 DOI: 10.1097/MPG.0000000000001345] [Cited by in Crossref: 27] [Cited by in F6Publishing: 6] [Article Influence: 5.4] [Reference Citation Analysis]
48 Hikmat O, Tzoulis C, Chong WK, Chentouf L, Klingenberg C, Fratter C, Carr LJ, Prabhakar P, Kumaraguru N, Gissen P, Cross JH, Jacques TS, Taanman J, Bindoff LA, Rahman S. The clinical spectrum and natural history of early-onset diseases due to DNA polymerase gamma mutations. Genet Med 2017;19:1217-25. [DOI: 10.1038/gim.2017.35] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 5.2] [Reference Citation Analysis]
49 Bratic A, Kauppila TE, Macao B, Grönke S, Siibak T, Stewart JB, Baggio F, Dols J, Partridge L, Falkenberg M, Wredenberg A, Larsson NG. Complementation between polymerase- and exonuclease-deficient mitochondrial DNA polymerase mutants in genomically engineered flies. Nat Commun 2015;6:8808. [PMID: 26554610 DOI: 10.1038/ncomms9808] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
50 Finsterer J, Zarrouk-Mahjoub S. Headache in mitochondrial disorders. Clin Neurol Neurosurg 2018;166:44-9. [PMID: 29408771 DOI: 10.1016/j.clineuro.2018.01.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
51 Espinós C, Palau F. Genetics and Pathogenesis of Inherited Ataxias and Spastic Paraplegias. In: Espinós C, Felipo V, Palau F, editors. Inherited Neuromuscular Diseases. Dordrecht: Springer Netherlands; 2009. pp. 263-96. [DOI: 10.1007/978-90-481-2813-6_18] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
52 Rantamäki M, Luoma P, Virta JJ, Rinne JO, Paetau A, Suomalainen A, Udd B. Do carriers of POLG mutation W748S have disease manifestations? Clin Genet 2007;72:532-7. [PMID: 17894835 DOI: 10.1111/j.1399-0004.2007.00908.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
53 Finsterer J. Inherited mitochondrial neuropathies. J Neurol Sci 2011;304:9-16. [PMID: 21402391 DOI: 10.1016/j.jns.2011.02.012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
54 Janssen W, Quaegebeur A, Van Goethem G, Ann L, Smets K, Vandenberghe R, Van Paesschen W. The spectrum of epilepsy caused by POLG mutations. Acta Neurol Belg 2016;116:17-25. [DOI: 10.1007/s13760-015-0499-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
55 Bindu PS, Arvinda H, Taly AB, Govindaraju C, Sonam K, Chiplunkar S, Kumar R, Gayathri N, Bharath Mm S, Nagappa M, Sinha S, Khan NA, Govindaraj P, Nunia V, Paramasivam A, Thangaraj K. Magnetic resonance imaging correlates of genetically characterized patients with mitochondrial disorders: A study from south India. Mitochondrion 2015;25:6-16. [PMID: 26341968 DOI: 10.1016/j.mito.2015.08.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
56 Lee WS, Sokol RJ. Mitochondrial hepatopathies: advances in genetics and pathogenesis. Hepatology. 2007;45:1555-1565. [PMID: 17538929 DOI: 10.1002/hep.21710] [Cited by in Crossref: 80] [Cited by in F6Publishing: 59] [Article Influence: 5.3] [Reference Citation Analysis]
57 Johansen KK, Bindoff LA, Rydland J, Aasly JO. Palatal tremor and facial dyskinesia in a patient with POLG1 mutation. Mov Disord 2008;23:1624-6. [PMID: 18581472 DOI: 10.1002/mds.22178] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
58 Hakonen AH, Goffart S, Marjavaara S, Paetau A, Cooper H, Mattila K, Lampinen M, Sajantila A, Lonnqvist T, Spelbrink JN, Suomalainen A. Infantile-onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion. Human Molecular Genetics 2008;17:3822-35. [DOI: 10.1093/hmg/ddn280] [Cited by in Crossref: 101] [Cited by in F6Publishing: 85] [Article Influence: 7.2] [Reference Citation Analysis]
59 Hansen N, Zwarg T, Wanke I, Zierz S, Kastrup O, Deschauer M. MELAS/SANDO overlap syndrome associated with POLG1 mutations. Neurol Sci 2012;33:209-12. [DOI: 10.1007/s10072-011-0631-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
60 Papetti L, Nicita F, Parisi P, Spalice A, Villa MP, Kasteleijn-nolst Trenité D. “Headache and epilepsy” — How are they connected? Epilepsy & Behavior 2013;26:386-93. [DOI: 10.1016/j.yebeh.2012.09.025] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
61 Bindoff LA. Mitochondrial function and pathology in status epilepticus: Mitochondria and Status Epilepticus. Epilepsia 2011;52:6-7. [DOI: 10.1111/j.1528-1167.2011.03223.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
62 Dimauro S. A history of mitochondrial diseases. J Inherit Metab Dis 2011;34:261-76. [PMID: 20490929 DOI: 10.1007/s10545-010-9082-x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 43] [Article Influence: 4.9] [Reference Citation Analysis]
63 Parisi P, Paolino MC, Raucci U, Della Vecchia N, Belcastro V, Villa MP, Striano P. Ictal Epileptic Headache: When Terminology Is Not a Moot Question. Front Neurol 2019;10:785. [PMID: 31396147 DOI: 10.3389/fneur.2019.00785] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
64 Ramón J, Vila-Julià F, Molina-Granada D, Molina-Berenguer M, Melià MJ, García-Arumí E, Torres-Torronteras J, Cámara Y, Martí R. Therapy Prospects for Mitochondrial DNA Maintenance Disorders. Int J Mol Sci 2021;22:6447. [PMID: 34208592 DOI: 10.3390/ijms22126447] [Reference Citation Analysis]
65 Lax NZ, Pienaar IS, Reeve AK, Hepplewhite PD, Jaros E, Taylor RW, Kalaria RN, Turnbull DM. Microangiopathy in the cerebellum of patients with mitochondrial DNA disease. Brain. 2012;135:1736-1750. [PMID: 22577219 DOI: 10.1093/brain/aws110] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
66 Copeland WC. Defects in mitochondrial DNA replication and human disease. Crit Rev Biochem Mol Biol 2012;47:64-74. [PMID: 22176657 DOI: 10.3109/10409238.2011.632763] [Cited by in Crossref: 115] [Cited by in F6Publishing: 104] [Article Influence: 11.5] [Reference Citation Analysis]
67 Rajakulendran S, Pitceathly RD, Taanman JW, Costello H, Sweeney MG, Woodward CE, Jaunmuktane Z, Holton JL, Jacques TS, Harding BN, Fratter C, Hanna MG, Rahman S. A Clinical, Neuropathological and Genetic Study of Homozygous A467T POLG-Related Mitochondrial Disease. PLoS One 2016;11:e0145500. [PMID: 26735972 DOI: 10.1371/journal.pone.0145500] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
68 van Westrhenen A, Cats EA, van den Munckhof B, van der Salm SM, Teunissen NW, Ferrier CH, Leijten FS, Geleijns KP. Specific EEG markers in POLG1 Alpers’ syndrome. Clinical Neurophysiology 2018;129:2127-31. [DOI: 10.1016/j.clinph.2018.07.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
69 Milone M, Brunetti-Pierri N, Tang LY, Kumar N, Mezei MM, Josephs K, Powell S, Simpson E, Wong LJ. Sensory ataxic neuropathy with ophthalmoparesis caused by POLG mutations. Neuromuscul Disord 2008;18:626-32. [PMID: 18585914 DOI: 10.1016/j.nmd.2008.05.009] [Cited by in Crossref: 58] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
70 Phillips J, Courel S, Rebelo AP, Bis-Brewer DM, Bardakjian T, Dankwa L, Hamedani AG, Züchner S, Scherer SS. POLG mutations presenting as Charcot-Marie-Tooth disease. J Peripher Nerv Syst 2019;24:213-8. [PMID: 30843307 DOI: 10.1111/jns.12313] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
71 Wolf NI, Rahman S, Schmitt B, Taanman J, Duncan AJ, Harting I, Wohlrab G, Ebinger F, Rating D, Bast T. Status epilepticus in children with Alpers’ disease caused by POLG1 mutations: EEG and MRI features. Epilepsia 2009;50:1596-607. [DOI: 10.1111/j.1528-1167.2008.01877.x] [Cited by in Crossref: 98] [Cited by in F6Publishing: 79] [Article Influence: 7.5] [Reference Citation Analysis]
72 Bennett B, Helbling D, Meng H, Jarzembowski J, Geurts AM, Friederich MW, Van Hove JLK, Lawlor MW, Dimmock DP. Potentially diagnostic electron paramagnetic resonance spectra elucidate the underlying mechanism of mitochondrial dysfunction in the deoxyguanosine kinase deficient rat model of a genetic mitochondrial DNA depletion syndrome. Free Radic Biol Med 2016;92:141-51. [PMID: 26773591 DOI: 10.1016/j.freeradbiomed.2016.01.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
73 Moslemi A, Darin N. Molecular genetic and clinical aspects of mitochondrial disorders in childhood. Mitochondrion 2007;7:241-52. [DOI: 10.1016/j.mito.2007.02.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
74 Squires RH, Ng V, Romero R, Ekong U, Hardikar W, Emre S, Mazariegos GV. Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Hepatology. 2014;60:362-398. [PMID: 24782219 DOI: 10.1002/hep.27191] [Cited by in Crossref: 101] [Cited by in F6Publishing: 77] [Article Influence: 12.6] [Reference Citation Analysis]
75 Tzoulis C, Papingji M, Fiskestrand T, Røste LS, Bindoff LA. Mitochondrial DNA depletion in progressive external ophthalmoplegia caused by POLG1 mutations. Acta Neurologica Scandinavica 2009;120:38-41. [DOI: 10.1111/j.1600-0404.2009.01212.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
76 Copeland WC. Inherited mitochondrial diseases of DNA replication. Annu Rev Med 2008;59:131-46. [PMID: 17892433 DOI: 10.1146/annurev.med.59.053006.104646] [Cited by in Crossref: 200] [Cited by in F6Publishing: 185] [Article Influence: 14.3] [Reference Citation Analysis]
77 Cheldi A, Ronchi D, Bordoni A, Bordo B, Lanfranconi S, Bellotti MG, Corti S, Lucchini V, Sciacco M, Moggio M, Baron P, Comi GP, Colombo A, Bersano A; Lombardia GENS collaborators. POLG1 mutations and stroke like episodes: a distinct clinical entity rather than an atypical MELAS syndrome. BMC Neurol 2013;13:8. [PMID: 23324391 DOI: 10.1186/1471-2377-13-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
78 Bianchin MM, Londero RG, Lima JE, Bigal ME. Migraine and Epilepsy: A Focus on Overlapping Clinical, Pathophysiological, Molecular, and Therapeutic Aspects. Curr Pain Headache Rep 2010;14:276-83. [DOI: 10.1007/s11916-010-0121-y] [Cited by in Crossref: 59] [Cited by in F6Publishing: 44] [Article Influence: 4.9] [Reference Citation Analysis]
79 Hikmat O, Eichele T, Tzoulis C, Bindoff LA. Understanding the Epilepsy in POLG Related Disease. Int J Mol Sci 2017;18:E1845. [PMID: 28837072 DOI: 10.3390/ijms18091845] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
80 Alberio S, Mineri R, Tiranti V, Zeviani M. Depletion of mtDNA: syndromes and genes. Mitochondrion 2007;7:6-12. [PMID: 17280874 DOI: 10.1016/j.mito.2006.11.010] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 4.3] [Reference Citation Analysis]
81 Wang H, Wang Y, Wang R, Li Y, Wang P, Li J, Du J. Hypertrophic olivary degeneration: A comprehensive review focusing on etiology. Brain Research 2019;1718:53-63. [DOI: 10.1016/j.brainres.2019.04.024] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
82 Copeland WC. The mitochondrial DNA polymerase in health and disease. Subcell Biochem 2010;50:211-22. [PMID: 20012584 DOI: 10.1007/978-90-481-3471-7_11] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
83 Kinghorn KJ, Kaliakatsos M, Blakely EL, Taylor RW, Rich P, Clarke A, Omer S. Hypertrophic olivary degeneration on magnetic resonance imaging in mitochondrial syndromes associated with POLG and SURF1 mutations. J Neurol 2013;260:3-9. [PMID: 22729384 DOI: 10.1007/s00415-012-6564-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
84 Cardenas JF, Amato RS. Compound heterozygous polymerase gamma gene mutation in a patient with Alpers disease. Semin Pediatr Neurol 2010;17:62-4. [PMID: 20434700 DOI: 10.1016/j.spen.2010.02.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
85 Desguerre I, Hully M, Rio M, Nabbout R. Mitochondrial disorders and epilepsy. Revue Neurologique 2014;170:375-80. [DOI: 10.1016/j.neurol.2014.03.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
86 Wedding IM, Kroken M, Henriksen SP, Selmer KK, Fiskerstrand T, Knappskog PM, Berge T, Tallaksen CM. Friedreich ataxia in Norway - an epidemiological, molecular and clinical study. Orphanet J Rare Dis 2015;10:108. [PMID: 26338206 DOI: 10.1186/s13023-015-0328-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
87 Sandford E, Bird TD, Li JZ, Burmeister M. PRICKLE2 Mutations Might Not Be Involved in Epilepsy. Am J Hum Genet 2016;98:588-9. [PMID: 26942291 DOI: 10.1016/j.ajhg.2016.01.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
88 Pronicka E, Weglewska-Jurkiewicz A, Pronicki M, Sykut-Cegielska J, Kowalski P, Pajdowska M, Jankowska I, Kotulska K, Kalicinski P, Jakobkiewicz-Banecka J, Wegrzyn G. Drug-resistant epilepsia and fulminant valproate liver toxicity. Alpers-Huttenlocher syndrome in two children confirmed post mortem by identification of p.W748S mutation in POLG gene. Med Sci Monit 2011;17:CR203-9. [PMID: 21455106 DOI: 10.12659/msm.881716] [Cited by in Crossref: 25] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
89 Reimann J, Kornblum C. Towards Central Nervous System Involvement in Adults with Hereditary Myopathies. J Neuromuscul Dis 2020;7:367-93. [PMID: 32773394 DOI: 10.3233/JND-200507] [Reference Citation Analysis]
90 McHugh JC, Lonergan R, Howley R, O'Rourke K, Taylor RW, Farrell M, Hutchinson M, Connolly S. Sensory ataxic neuropathy dysarthria and ophthalmoparesis (SANDO) in a sibling pair with a homozygous p.A467T POLG mutation. Muscle Nerve 2010;41:265-9. [PMID: 19813183 DOI: 10.1002/mus.21494] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
91 Hayhurst H, Anagnostou ME, Bogle HJ, Grady JP, Taylor RW, Bindoff LA, McFarland R, Turnbull DM, Lax NZ. Dissecting the neuronal vulnerability underpinning Alpers' syndrome: a clinical and neuropathological study. Brain Pathol 2019;29:97-113. [PMID: 30021052 DOI: 10.1111/bpa.12640] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
92 Sanderson KG, Millar E, Tumber A, Klatt R, Sondheimer N, Vincent A. Rod bipolar cell dysfunction in POLG retinopathy. Doc Ophthalmol 2021;142:111-8. [PMID: 32567010 DOI: 10.1007/s10633-020-09777-w] [Reference Citation Analysis]
93 Dimauro S. Mitochondrial myopathies. Current Opinion in Rheumatology 2006;18:636-41. [DOI: 10.1097/01.bor.0000245729.17759.f2] [Cited by in Crossref: 62] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
94 Bindu PS, Taly AB, Sonam K, Govindaraju C, Arvinda HR, Gayathri N, Bharath MM, Ranjith D, Nagappa M, Sinha S. Bilateral hypertrophic olivary nucleus degeneration on magnetic resonance imaging in children with Leigh and Leigh-like syndrome. Br J Radiol. 2014;87:20130478. [PMID: 24470583 DOI: 10.1259/bjr.20130478] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
95 Liang KX, Kristiansen CK, Mostafavi S, Vatne GH, Zantingh GA, Kianian A, Tzoulis C, Høyland LE, Ziegler M, Perez RM, Furriol J, Zhang Z, Balafkan N, Hong Y, Siller R, Sullivan GJ, Bindoff LA. Disease-specific phenotypes in iPSC-derived neural stem cells with POLG mutations. EMBO Mol Med 2020;12:e12146. [PMID: 32840960 DOI: 10.15252/emmm.202012146] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
96 Tan RY, Neligan A, Shorvon SD. The uncommon causes of status epilepticus: a systematic review. Epilepsy Res 2010;91:111-22. [PMID: 20709500 DOI: 10.1016/j.eplepsyres.2010.07.015] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
97 Delgado-alvarado M, de la Riva P, Jiménez-urbieta H, Gago B, Gabilondo A, Bornstein B, Rodríguez-oroz MC. Parkinsonism, cognitive deficit and behavioural disturbance caused by a novel mutation in the polymerase gamma gene. Journal of the Neurological Sciences 2015;350:93-7. [DOI: 10.1016/j.jns.2015.02.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
98 Saneto RP, Cohen BH, Copeland WC, Naviaux RK. Alpers-Huttenlocher syndrome. Pediatr Neurol 2013;48:167-78. [PMID: 23419467 DOI: 10.1016/j.pediatrneurol.2012.09.014] [Cited by in Crossref: 54] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
99 Hudson G, Chinnery PF. Mitochondrial DNA polymerase-gamma and human disease. Hum Mol Genet 2006;15 Spec No 2:R244-52. [PMID: 16987890 DOI: 10.1093/hmg/ddl233] [Cited by in Crossref: 143] [Cited by in F6Publishing: 140] [Article Influence: 8.9] [Reference Citation Analysis]
100 Boes M, Bauer J, Urbach H, Elger CE, Frank S, Baron M, Zsurka G, Kunz WS, Kornblum C. Proof of progression over time: finally fulminant brain, muscle, and liver affection in Alpers syndrome associated with the A467T POLG1 mutation. Seizure 2009;18:232-4. [PMID: 18783964 DOI: 10.1016/j.seizure.2008.08.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
101 Tuladhar AM, Meijer FJA, Warrenburg BP. POLG mutation presenting with late-onset jerky torticollis. J Neurol 2013;260:903-5. [DOI: 10.1007/s00415-012-6776-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
102 Lax NZ, Whittaker RG, Hepplewhite PD, Reeve AK, Blakely EL, Jaros E, Ince PG, Taylor RW, Fawcett PR, Turnbull DM. Sensory neuronopathy in patients harbouring recessive polymerase γ mutations. Brain 2012;135:62-71. [PMID: 22189570 DOI: 10.1093/brain/awr326] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
103 McFarland R, Hudson G, Taylor RW, Green SH, Hodges S, McKiernan PJ, Chinnery PF, Ramesh V. Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase γ (POLG1). BMJ Case Rep 2009;2009:bcr12. [PMID: 21686371 DOI: 10.1136/bcr.12.2008.1303] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
104 Hikmat O, Tzoulis C, Klingenberg C, Rasmussen M, Tallaksen CME, Brodtkorb E, Fiskerstrand T, McFarland R, Rahman S, Bindoff LA. The presence of anaemia negatively influences survival in patients with POLG disease. J Inherit Metab Dis 2017;40:861-6. [PMID: 28865037 DOI: 10.1007/s10545-017-0084-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
105 Béreau M, Anheim M, Echaniz-Laguna A, Magot A, Verny C, Goideau-Sevrain M, Barth M, Amati-Bonneau P, Allouche S, Ayrignac X, Bédat-Millet AL, Guyant-Maréchal L, Kuntzer T, Ochsner F, Petiot P, Vial C, Omer S, Sole G, Taieb G, Carvalho N, Tio G, Kremer S, Acquaviva-Bourdain C, de Camaret BM, Tranchant C. The wide POLG-related spectrum: An integrated view. J Neurol Sci 2016;368:70-6. [PMID: 27538604 DOI: 10.1016/j.jns.2016.06.062] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
106 Kurt B, Jaeken J, Van Hove J, Lagae L, Löfgren A, Everman DB, Jayakar P, Naini A, Wierenga KJ, Van Goethem G, Copeland WC, DiMauro S. A novel POLG gene mutation in 4 children with Alpers-like hepatocerebral syndromes. Arch Neurol 2010;67:239-44. [PMID: 20142534 DOI: 10.1001/archneurol.2009.332] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
107 Wesół-Kucharska D, Rokicki D, Jezela-Stanek A. Epilepsy in Mitochondrial Diseases-Current State of Knowledge on Aetiology and Treatment. Children (Basel) 2021;8:532. [PMID: 34206602 DOI: 10.3390/children8070532] [Reference Citation Analysis]
108 Bender F, Timmann D, van de Warrenburg BP, Adarmes-Gómez AD, Bender B, Thieme A, Synofzik M, Schöls L. Natural History of Polymerase Gamma-Related Ataxia. Mov Disord 2021. [PMID: 34288125 DOI: 10.1002/mds.28713] [Reference Citation Analysis]
109 Menezes MP, Rahman S, Bhattacharya K, Clark D, Christodoulou J, Ellaway C, Farrar M, Pitt M, Sampaio H, Ware TL, Wedatilake Y, Thorburn DR, Ryan MM, Ouvrier R. Neurophysiological profile of peripheral neuropathy associated with childhood mitochondrial disease. Mitochondrion 2016;30:162-7. [PMID: 27475922 DOI: 10.1016/j.mito.2016.07.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
110 Roshal D, Glosser D, Zangaladze A. Parieto-occipital lobe epilepsy caused by a POLG1 compound heterozygous A467T/W748S genotype. Epilepsy Behav 2011;21:206-10. [PMID: 21515089 DOI: 10.1016/j.yebeh.2011.03.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
111 Brinjikji W, Swanson JW, Zabel C, Dyck PJ, Tracy JA, Gavrilova RH. Stroke and Stroke-Like Symptoms in Patients with Mutations in the POLG1 Gene. JIMD Rep 2011;1:89-96. [PMID: 23430834 DOI: 10.1007/8904_2011_22] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
112 Viscomi C, Zeviani M. MtDNA-maintenance defects: syndromes and genes. J Inherit Metab Dis 2017;40:587-99. [PMID: 28324239 DOI: 10.1007/s10545-017-0027-5] [Cited by in Crossref: 84] [Cited by in F6Publishing: 76] [Article Influence: 16.8] [Reference Citation Analysis]
113 Komulainen T, Hinttala R, Kärppä M, Pajunen L, Finnilä S, Tuominen H, Rantala H, Hassinen I, Majamaa K, Uusimaa J. POLG1 p.R722H mutation associated with multiple mtDNA deletions and a neurological phenotype. BMC Neurol 2010;10:29. [PMID: 20438629 DOI: 10.1186/1471-2377-10-29] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
114 Orsucci D, Ienco EC, Siciliano G, Mancuso M. Mitochondrial disorders and drugs: what every physician should know. Drugs Context 2019;8:212588. [PMID: 31391854 DOI: 10.7573/dic.212588] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
115 Oliveira MT, Pontes CB, Ciesielski GL. Roles of the mitochondrial replisome in mitochondrial DNA deletion formation. Genet Mol Biol 2020;43:e20190069. [PMID: 32141473 DOI: 10.1590/1678-4685-GMB-2019-0069] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
116 Koch J, Freisinger P, Feichtinger RG, Zimmermann FA, Rauscher C, Wagentristl HP, Konstantopoulou V, Seidl R, Haack TB, Prokisch H, Ahting U, Sperl W, Mayr JA, Maier EM. Mutations in TTC19: expanding the molecular, clinical and biochemical phenotype. Orphanet J Rare Dis 2015;10:40. [PMID: 25887401 DOI: 10.1186/s13023-015-0254-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
117 van den Maagdenberg AM, Haan J, Terwindt GM, Ferrari MD. Migraine: gene mutations and functional consequences: . Current Opinion in Neurology 2007;20:299-305. [DOI: 10.1097/wco.0b013e3281338d1f] [Cited by in Crossref: 97] [Cited by in F6Publishing: 34] [Article Influence: 6.5] [Reference Citation Analysis]
118 Tzoulis C, Neckelmann G, Mørk SJ, Engelsen BE, Viscomi C, Moen G, Ersland L, Zeviani M, Bindoff LA. Localized cerebral energy failure in DNA polymerase gamma-associated encephalopathy syndromes. Brain 2010;133:1428-37. [PMID: 20400524 DOI: 10.1093/brain/awq067] [Cited by in Crossref: 56] [Cited by in F6Publishing: 42] [Article Influence: 4.7] [Reference Citation Analysis]
119 Uusimaa J, Gowda V, McShane A, Smith C, Evans J, Shrier A, Narasimhan M, O'Rourke A, Rajabally Y, Hedderly T, Cowan F, Fratter C, Poulton J. Prospective study of POLG mutations presenting in children with intractable epilepsy: prevalence and clinical features. Epilepsia 2013;54:1002-11. [PMID: 23448099 DOI: 10.1111/epi.12115] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
120 Deepha S, Govindaraj P, Sankaran BP, Chiplunkar S, Kashinkunti C, Nunia V, Nagappa M, Sinha S, Khanna T, Thangaraj K, Taly AB, Gayathri N. Clinico-pathological and Molecular Spectrum of Mitochondrial Polymerase γ Mutations in a Cohort from India. J Mol Neurosci 2021. [PMID: 33469851 DOI: 10.1007/s12031-020-01765-8] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
121 Silva-Pinheiro P, Pardo-Hernández C, Reyes A, Tilokani L, Mishra A, Cerutti R, Li S, Rozsivalova DH, Valenzuela S, Dogan SA, Peter B, Fernández-Silva P, Trifunovic A, Prudent J, Minczuk M, Bindoff L, Macao B, Zeviani M, Falkenberg M, Viscomi C. DNA polymerase gamma mutations that impair holoenzyme stability cause catalytic subunit depletion. Nucleic Acids Res 2021;49:5230-48. [PMID: 33956154 DOI: 10.1093/nar/gkab282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
122 Chinnery PF. Mutations in SUCLA2: a tandem ride back to the Krebs cycle. Brain 2007;130:606-9. [DOI: 10.1093/brain/awm023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
123 Visser NA, Braun KP, Leijten FS, van Nieuwenhuizen O, Wokke JH, van den Bergh WM. Magnesium treatment for patients with refractory status epilepticus due to POLG1-mutations. J Neurol 2011;258:218-22. [PMID: 20803213 DOI: 10.1007/s00415-010-5721-2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
124 Papadopoulos C, Wahbi K, Behin A, Bougouin W, Stojkovic T, Leonard-Louis S, Berber N, Lombès A, Duboc D, Jardel C, Eymard B, Laforêt P. Incidence and predictors of total mortality in 267 adults presenting with mitochondrial diseases. J Inherit Metab Dis 2020;43:459-66. [PMID: 31652339 DOI: 10.1002/jimd.12185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
125 Hanisch F, Kornhuber M, Alston CL, Taylor RW, Deschauer M, Zierz S. SANDO syndrome in a cohort of 107 patients with CPEO and mitochondrial DNA deletions. J Neurol Neurosurg Psychiatry 2015;86:630-4. [PMID: 25143630 DOI: 10.1136/jnnp-2013-306748] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
126 Gramstad A, Bindoff LA, Lillebø A, Tzoulis C, Engelsen BA. Neuropsychological performance in patients with POLG1 mutations and the syndrome of mitochondrial spinocerebellar ataxia and epilepsy. Epilepsy & Behavior 2009;16:172-4. [DOI: 10.1016/j.yebeh.2009.01.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
127 Hikmat O, Vederhus BJ, Benestad MR, Engeset IME, Klingenberg C, Rasmussen M, Tallaksen CM, Brodtkorb E, Elgen IB, Bindoff LA. Mental health and health related quality of life in mitochondrial POLG disease. Mitochondrion 2020;55:95-9. [PMID: 32976988 DOI: 10.1016/j.mito.2020.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
128 Hakonen AH, Davidzon G, Salemi R, Bindoff LA, Van Goethem G, Dimauro S, Thorburn DR, Suomalainen A. Abundance of the POLG disease mutations in Europe, Australia, New Zealand, and the United States explained by single ancient European founders. Eur J Hum Genet 2007;15:779-83. [DOI: 10.1038/sj.ejhg.5201831] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
129 Spinazzola A, Invernizzi F, Carrara F, Lamantea E, Donati A, Dirocco M, Giordano I, Meznaric-petrusa M, Baruffini E, Ferrero I, Zeviani M. Clinical and molecular features of mitochondrial DNA depletion syndromes. J Inherit Metab Dis 2009;32:143-58. [DOI: 10.1007/s10545-008-1038-z] [Cited by in Crossref: 127] [Cited by in F6Publishing: 114] [Article Influence: 9.1] [Reference Citation Analysis]
130 Matricardi S, Canafoglia L, Ardissone A, Moroni I, Ragona F, Ghezzi D, Lamantea E, Nardocci N, Franceschetti S, Granata T. Epileptic phenotypes in children with early-onset mitochondrial diseases. Acta Neurol Scand 2019;140:184-93. [PMID: 31102535 DOI: 10.1111/ane.13130] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
131 Finsterer J, Segall L. Drugs interfering with mitochondrial disorders. Drug and Chemical Toxicology 2010;33:138-51. [DOI: 10.3109/01480540903207076] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 4.3] [Reference Citation Analysis]
132 Galassi G, Lamantea E, Invernizzi F, Tavani F, Pisano I, Ferrero I, Palmieri L, Zeviani M. Additive effects of POLG1 and ANT1 mutations in a complex encephalomyopathy. Neuromuscul Disord 2008;18:465-70. [PMID: 18504126 DOI: 10.1016/j.nmd.2008.03.013] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
133 Zeviani M, Carelli V. Mitochondrial disorders. Curr Opin Neurol 2007;20:564-71. [PMID: 17885446 DOI: 10.1097/WCO.0b013e3282ef58cd] [Cited by in Crossref: 97] [Cited by in F6Publishing: 39] [Article Influence: 6.5] [Reference Citation Analysis]
134 McKiernan P. Acute liver failure after valproate exposure: Liver transplantation may be indicated beyond childhood. Liver Transpl 2014;20:1287-9. [PMID: 25179873 DOI: 10.1002/lt.23988] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
135 Sapio MR, Salzmann A, Vessaz M, Crespel A, Lyons PJ, Malafosse A, Fricker LD. Naturally occurring carboxypeptidase A6 mutations: effect on enzyme function and association with epilepsy. J Biol Chem 2012;287:42900-9. [PMID: 23105115 DOI: 10.1074/jbc.M112.414094] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
136 Orsucci D, Caldarazzo Ienco E, Mancuso M, Siciliano G. POLG1-Related and other “Mitochondrial Parkinsonisms”: an Overview. J Mol Neurosci 2011;44:17-24. [DOI: 10.1007/s12031-010-9488-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
137 Copeland WC. Defects of mitochondrial DNA replication. J Child Neurol 2014;29:1216-24. [PMID: 24985751 DOI: 10.1177/0883073814537380] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
138 Chaussenot A, Paquis-flucklinger V. An overview of neurological and neuromuscular signs in mitochondrial diseases. Revue Neurologique 2014;170:323-38. [DOI: 10.1016/j.neurol.2014.03.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
139 Nagappa M, Bindu PS, Taly AB, Sonam K, Shwetha C, Kumar R, Gayathri N, Srinivas-Bharath MM, Arvinda HR, Sinha S, Paramasivam A, Thangaraj K. Palatal Tremor in POLG-Associated Ataxia. Mov Disord Clin Pract 2015;2:318-20. [PMID: 30363534 DOI: 10.1002/mdc3.12195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
140 Reeve A, Meagher M, Lax N, Simcox E, Hepplewhite P, Jaros E, Turnbull D. The impact of pathogenic mitochondrial DNA mutations on substantia nigra neurons. J Neurosci 2013;33:10790-801. [PMID: 23804100 DOI: 10.1523/JNEUROSCI.3525-12.2013] [Cited by in Crossref: 56] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
141 Verrotti A, Striano P, Belcastro V, Matricardi S, Villa MP, Parisi P. Migralepsy and related conditions: Advances in pathophysiology and classification. Seizure 2011;20:271-5. [DOI: 10.1016/j.seizure.2011.02.012] [Cited by in Crossref: 51] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
142 Cohen BH, Naviaux RK. The clinical diagnosis of POLG disease and other mitochondrial DNA depletion disorders. Methods 2010;51:364-73. [DOI: 10.1016/j.ymeth.2010.05.008] [Cited by in Crossref: 75] [Cited by in F6Publishing: 62] [Article Influence: 6.3] [Reference Citation Analysis]
143 Anheim M, Tranchant C. [Peripheral neuropathies associated with hereditary cerebellar ataxias]. Rev Neurol (Paris) 2011;167:72-6. [PMID: 21195440 DOI: 10.1016/j.neurol.2010.07.041] [Reference Citation Analysis]
144 Piekutowska-abramczuk D, Kaliszewska M, Sułek A, Jurkowska N, Ołtarzewski M, Jabłońska E, Trubicka J, Głowacka A, Ciara E, Kowalski P, Langiewicz-wojciechowska K, Tesarova M, Zeman J, Kierdaszuk B, Kuczyński D, Chmielewski D, Szymańska E, Bakuła A, Łusakowska A, Lipowska M, Brodacki B, Pera J, Dorobek M, Rydzanicz M, Płoski R, Chrzanowska KH, Bartnik E, Placha G, Kamińska A, Kostera-pruszczyk A, Krajewska-walasek M, Tońska K, Pronicka E. The frequency of mitochondrial polymerase gamma related disorders in a large Polish population cohort. Mitochondrion 2019;47:179-87. [DOI: 10.1016/j.mito.2018.11.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
145 Khan A, Trevenen C, Wei XC, Sarnat HB, Payne E, Kirton A. Alpers syndrome: the natural history of a case highlighting neuroimaging, neuropathology, and fat metabolism. J Child Neurol 2012;27:636-40. [PMID: 22114215 DOI: 10.1177/0883073811423973] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
146 Lonnqvist T, Paetau A, Valanne L, Pihko H. Recessive twinkle mutations cause severe epileptic encephalopathy. Brain 2009;132:1553-62. [DOI: 10.1093/brain/awp045] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 5.3] [Reference Citation Analysis]
147 Tchikviladzé M, Gilleron M, Maisonobe T, Galanaud D, Laforêt P, Durr A, Eymard B, Mochel F, Ogier H, Béhin A, Stojkovic T, Degos B, Gourfinkel-an I, Sedel F, Anheim M, Elbaz A, Viala K, Vidailhet M, Brice A, Jardel C, Lombès A. A diagnostic flow chart for POLG- related diseases based on signs sensitivity and specificity. J Neurol Neurosurg Psychiatry 2015;86:646-54. [DOI: 10.1136/jnnp-2013-306799] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
148 Anheim M. [Autosomal recessive cerebellar ataxias]. Rev Neurol (Paris) 2011;167:372-84. [PMID: 21087783 DOI: 10.1016/j.neurol.2010.07.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
149 El-Hattab AW, Scaglia F. Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options. Neurotherapeutics 2013;10:186-98. [PMID: 23385875 DOI: 10.1007/s13311-013-0177-6] [Cited by in Crossref: 163] [Cited by in F6Publishing: 142] [Article Influence: 18.1] [Reference Citation Analysis]
150 Delonlay P, Rötig A, Sarnat HB. Respiratory chain deficiencies. Pediatric Neurology Part III. Elsevier; 2013. pp. 1651-66. [DOI: 10.1016/b978-0-444-59565-2.00033-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
151 Balafkan N, Tzoulis C, Müller B, Haugarvoll K, Tysnes OB, Larsen JP, Bindoff LA. Number of CAG repeats in POLG1 and its association with Parkinson disease in the Norwegian population. Mitochondrion 2012;12:640-3. [PMID: 22963882 DOI: 10.1016/j.mito.2012.08.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
152 Hikmat O, Naess K, Engvall M, Klingenberg C, Rasmussen M, Tallaksen CME, Brodtkorb E, Fiskerstrand T, Isohanni P, Uusimaa J, Darin N, Rahman S, Bindoff LA. Elevated cerebrospinal fluid protein in POLG -related epilepsy: Diagnostic and prognostic implications. Epilepsia 2018;59:1595-602. [DOI: 10.1111/epi.14459] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
153 Lutz RE, Dimmock D, Schmitt ES, Zhang Q, Tang LY, Reyes C, Truemper E, McComb RD, Hernandez A, Basinger A, Wong LJ. De novo mutations in POLG presenting with acute liver failure or encephalopathy. J Pediatr Gastroenterol Nutr 2009;49:126-9. [PMID: 19252446 DOI: 10.1097/MPG.0b013e31817d9cad] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
154 Saneto RP, Naviaux RK. Polymerase gamma disease through the ages. Dev Disabil Res Revs 2010;16:163-74. [DOI: 10.1002/ddrr.105] [Cited by in Crossref: 55] [Cited by in F6Publishing: 46] [Article Influence: 4.6] [Reference Citation Analysis]
155 Koessler M, Haberlandt E, Karall D, Baumann M, Höller A, Scholl-Bürgi S. Ketogenic diet in a patient with refractory status epilepticus due to POLG mutation. JIMD Rep 2021;57:3-8. [PMID: 33473333 DOI: 10.1002/jmd2.12169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
156 Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies. Prog Retin Eye Res 2011;30:81-114. [PMID: 21112411 DOI: 10.1016/j.preteyeres.2010.11.002] [Cited by in Crossref: 325] [Cited by in F6Publishing: 293] [Article Influence: 27.1] [Reference Citation Analysis]
157 Tzoulis C, Tran GT, Coxhead J, Bertelsen B, Lilleng PK, Balafkan N, Payne B, Miletic H, Chinnery PF, Bindoff LA. Molecular pathogenesis of polymerase γ-related neurodegeneration. Ann Neurol 2014;76:66-81. [PMID: 24841123 DOI: 10.1002/ana.24185] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 6.4] [Reference Citation Analysis]
158 Hegarty R, Gibson P, Sambrotta M, Strautnieks S, Foskett P, Ellard S, Baptista J, Lillis S, Bansal S, Vara R, Dhawan A, Grammatikopoulos T, Thompson RJ. Study of Acute Liver Failure in Children Using Next Generation Sequencing Technology. J Pediatr 2021;236:124-30. [PMID: 34023347 DOI: 10.1016/j.jpeds.2021.05.041] [Reference Citation Analysis]
159 Kaliszewska M, Kruszewski J, Kierdaszuk B, Kostera-Pruszczyk A, Nojszewska M, Łusakowska A, Vizueta J, Sabat D, Lutyk D, Lower M, Piekutowska-Abramczuk D, Kaniak-Golik A, Pronicka E, Kamińska A, Bartnik E, Golik P, Tońska K. Yeast model analysis of novel polymerase gamma variants found in patients with autosomal recessive mitochondrial disease. Hum Genet 2015;134:951-66. [PMID: 26077851 DOI: 10.1007/s00439-015-1578-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
160 . Bibliography. Current world literature. Neuro-muscular diseases: nerve. Curr Opin Neurol 2007;20:600-4. [PMID: 17885452 DOI: 10.1097/WCO.0b013e3282efeb3b] [Reference Citation Analysis]
161 Bauer PR, Tolner EA, Keezer MR, Ferrari MD, Sander JW. Headache in people with epilepsy. Nat Rev Neurol 2021;17:529-44. [PMID: 34312533 DOI: 10.1038/s41582-021-00516-6] [Reference Citation Analysis]
162 Harati Y, Bosch EP. Disorders of Peripheral Nerves. Neurology in Clinical Practice. Elsevier; 2008. pp. 2249-355. [DOI: 10.1016/b978-0-7506-7525-3.50118-7] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
163 Saneto RP, Friedman SD, Shaw DW. Neuroimaging of mitochondrial disease. Mitochondrion 2008;8:396-413. [PMID: 18590986 DOI: 10.1016/j.mito.2008.05.003] [Cited by in Crossref: 137] [Cited by in F6Publishing: 114] [Article Influence: 9.8] [Reference Citation Analysis]
164 Chan SS, Longley MJ, Copeland WC. Modulation of the W748S mutation in DNA polymerase gamma by the E1143G polymorphismin mitochondrial disorders. Hum Mol Genet 2006;15:3473-83. [PMID: 17088268 DOI: 10.1093/hmg/ddl424] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 4.3] [Reference Citation Analysis]
165 Valton L, Benaiteau M, Denuelle M, Rulquin F, Hachon Le Camus C, Hein C, Viguier A, Curot J. Etiological assessment of status epilepticus. Rev Neurol (Paris) 2020;176:408-26. [PMID: 32331701 DOI: 10.1016/j.neurol.2019.12.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
166 Holt IJ, Jacobs HT. Unique features of DNA replication in mitochondria: a functional and evolutionary perspective. Bioessays 2014;36:1024-31. [PMID: 25220172 DOI: 10.1002/bies.201400052] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
167 Longo MG, Vairo F, Souza CF, Giugliani R, Vedolin LM. Brain imaging and genetic risk in the pediatric population, part 1: inherited metabolic diseases. Neuroimaging Clin N Am 2015;25:31-51. [PMID: 25476511 DOI: 10.1016/j.nic.2014.09.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
168 Vital A, Lepreux S, Vital C. Peripheral neuropathy and parkinsonism: a large clinical and pathogenic spectrum. J Peripher Nerv Syst 2014;19:333-42. [PMID: 25582874 DOI: 10.1111/jns.12099] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
169 Hunter MF, Peters H, Salemi R, Thorburn D, Mackay MT. Alpers syndrome with mutations in POLG: clinical and investigative features. Pediatr Neurol. 2011;45:311-318. [PMID: 22000311 DOI: 10.1016/j.pediatrneurol.2011.07.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
170 Paus S, Zsurka G, Baron M, Deschauer M, Bamberg C, Klockgether T, Kunz WS, Kornblum C. Apraxia of lid opening mimicking ptosis in compound heterozygosity for A467T and W748S POLG1 mutations. Mov Disord 2008;23:1286-8. [PMID: 18546343 DOI: 10.1002/mds.22135] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
171 Anagnostou M, Ng YS, Taylor RW, Mcfarland R. Epilepsy due to mutations in the mitochondrial polymerase gamma (POLG) gene: A clinical and molecular genetic review. Epilepsia 2016;57:1531-45. [DOI: 10.1111/epi.13508] [Cited by in Crossref: 36] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
172 Hikmat O, Naess K, Engvall M, Klingenberg C, Rasmussen M, Tallaksen CM, Brodtkorb E, Ostergaard E, de Coo IFM, Pias-Peleteiro L, Isohanni P, Uusimaa J, Darin N, Rahman S, Bindoff LA. Simplifying the clinical classification of polymerase gamma (POLG) disease based on age of onset; studies using a cohort of 155 cases. J Inherit Metab Dis 2020;43:726-36. [PMID: 32391929 DOI: 10.1002/jimd.12211] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
173 Specchio N, Pietrafusa N, Calabrese C, Trivisano M, Pepi C, de Palma L, Ferretti A, Curatolo P, Vigevano F. POLG1-Related Epilepsy: Review of Diagnostic and Therapeutic Findings. Brain Sci 2020;10:E768. [PMID: 33113942 DOI: 10.3390/brainsci10110768] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
174 Manto M, Marmolino D. Cerebellar ataxias. Current Opinion in Neurology 2009;22:419-29. [DOI: 10.1097/wco.0b013e32832b9897] [Cited by in Crossref: 125] [Cited by in F6Publishing: 60] [Article Influence: 9.6] [Reference Citation Analysis]
175 De Greef E, Christodoulou J, Alexander IE, Shun A, O'Loughlin EV, Thorburn DR, Jermyn V, Stormon MO. Mitochondrial respiratory chain hepatopathies: role of liver transplantation. A case series of five patients. JIMD Rep 2012;4:5-11. [PMID: 23430890 DOI: 10.1007/8904_2011_29] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
176 Remes A, Hinttala R, Kärppä M, Soini H, Takalo R, Uusimaa J, Majamaa K. Parkinsonism associated with the homozygous W748S mutation in the POLG1 gene. Parkinsonism & Related Disorders 2008;14:652-4. [DOI: 10.1016/j.parkreldis.2008.01.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
177 Lee WS, Sokol RJ. Liver disease in mitochondrial disorders. Semin Liver Dis. 2007;27:259-273. [PMID: 17682973 DOI: 10.1055/s-2007-985071] [Cited by in Crossref: 62] [Cited by in F6Publishing: 46] [Article Influence: 4.1] [Reference Citation Analysis]
178 Hynynen J, Komulainen T, Tukiainen E, Nordin A, Arola J, Kälviäinen R, Jutila L, Röyttä M, Hinttala R, Majamaa K, Mäkisalo H, Uusimaa J. Acute liver failure after valproate exposure in patients with POLG1 mutations and the prognosis after liver transplantation. Liver Transpl 2014;20:1402-12. [PMID: 25065347 DOI: 10.1002/lt.23965] [Cited by in Crossref: 45] [Cited by in F6Publishing: 31] [Article Influence: 5.6] [Reference Citation Analysis]
179 Mancuso M, Orsucci D, Angelini C, Bertini E, Catteruccia M, Pegoraro E, Carelli V, Valentino ML, Comi GP, Minetti C, Bruno C, Moggio M, Ienco EC, Mongini T, Vercelli L, Primiano G, Servidei S, Tonin P, Scarpelli M, Toscano A, Musumeci O, Moroni I, Uziel G, Santorelli FM, Nesti C, Filosto M, Lamperti C, Zeviani M, Siciliano G. Myoclonus in mitochondrial disorders: Mitochondrial Myoclonus. Mov Disord 2014;29:722-8. [DOI: 10.1002/mds.25839] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
180 Ashley N, O'Rourke A, Smith C, Adams S, Gowda V, Zeviani M, Brown GK, Fratter C, Poulton J. Depletion of mitochondrial DNA in fibroblast cultures from patients with POLG1 mutations is a consequence of catalytic mutations. Hum Mol Genet 2008;17:2496-506. [PMID: 18487244 DOI: 10.1093/hmg/ddn150] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
181 Rahman S. Gastrointestinal and hepatic manifestations of mitochondrial disorders. J Inherit Metab Dis. 2013;36:659-673. [PMID: 23674168 DOI: 10.1007/s10545-013-9614-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
182 Bindoff LA, Engelsen BA. Mitochondrial diseases and epilepsy. Epilepsia 2012;53 Suppl 4:92-7. [PMID: 22946726 DOI: 10.1111/j.1528-1167.2012.03618.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 6.3] [Reference Citation Analysis]
183 Vernon HJ, Bindoff LA. Mitochondrial ataxias. Handb Clin Neurol 2018;155:129-41. [PMID: 29891055 DOI: 10.1016/B978-0-444-64189-2.00009-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
184 Stumpf JD, Saneto RP, Copeland WC. Clinical and molecular features of POLG-related mitochondrial disease. Cold Spring Harb Perspect Biol 2013;5:a011395. [PMID: 23545419 DOI: 10.1101/cshperspect.a011395] [Cited by in Crossref: 81] [Cited by in F6Publishing: 67] [Article Influence: 9.0] [Reference Citation Analysis]
185 Wong LJ, Naviaux RK, Brunetti-Pierri N, Zhang Q, Schmitt ES, Truong C, Milone M, Cohen BH, Wical B, Ganesh J, Basinger AA, Burton BK, Swoboda K, Gilbert DL, Vanderver A, Saneto RP, Maranda B, Arnold G, Abdenur JE, Waters PJ, Copeland WC. Molecular and clinical genetics of mitochondrial diseases due to POLG mutations. Hum Mutat 2008;29:E150-72. [PMID: 18546365 DOI: 10.1002/humu.20824] [Cited by in Crossref: 201] [Cited by in F6Publishing: 181] [Article Influence: 16.8] [Reference Citation Analysis]
186 Synofzik M, Srulijes K, Godau J, Berg D, Schöls L. Characterizing POLG ataxia: clinics, electrophysiology and imaging. Cerebellum 2012;11:1002-11. [PMID: 22528963 DOI: 10.1007/s12311-012-0378-2] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
187 Katirji B, Koontz D. Disorders of Peripheral Nerves. Neurology in Clinical Practice. Elsevier; 2012. pp. 1915-2015. [DOI: 10.1016/b978-1-4377-0434-1.00101-8] [Cited by in Crossref: 9] [Article Influence: 0.9] [Reference Citation Analysis]
188 Rossi M, van der Veen S, Merello M, Tijssen MAJ, van de Warrenburg B. Myoclonus-Ataxia Syndromes: A Diagnostic Approach. Mov Disord Clin Pract 2021;8:9-24. [PMID: 33426154 DOI: 10.1002/mdc3.13106] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
189 Mancuso M, Orsucci D, Filosto M, Simoncini C, Siciliano G. Drugs and mitochondrial diseases: 40 queries and answers. Expert Opinion on Pharmacotherapy 2012;13:527-43. [DOI: 10.1517/14656566.2012.657177] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
190 Sonam K, Bindu PS, Srinivas Bharath MM, Govindaraj P, Gayathri N, Arvinda HR, Chiplunkar S, Nagappa M, Sinha S, Khan NA, Nunia V, Paramasivam A, Thangaraj K, Taly AB. Mitochondrial oxidative phosphorylation disorders in children: Phenotypic, genotypic and biochemical correlations in 85 patients from South India. Mitochondrion 2017;32:42-9. [PMID: 27826120 DOI: 10.1016/j.mito.2016.11.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
191 Hikmat O, Naess K, Engvall M, Klingenberg C, Rasmussen M, Tallaksen CME, Samsonsen C, Brodtkorb E, Ostergaard E, de Coo R, Pias-Peleteiro L, Isohanni P, Uusimaa J, Darin N, Rahman S, Bindoff LA. The impact of gender, puberty, and pregnancy in patients with POLG disease. Ann Clin Transl Neurol 2020;7:2019-25. [PMID: 32949115 DOI: 10.1002/acn3.51199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
192 Chrysostomou A, Grady JP, Laude A, Taylor RW, Turnbull DM, Lax NZ. Investigating complex I deficiency in Purkinje cells and synapses in patients with mitochondrial disease. Neuropathol Appl Neurobiol 2016;42:477-92. [PMID: 26337858 DOI: 10.1111/nan.12282] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
193 Horvath R, Gorman G, Chinnery PF. How can we treat mitochondrial encephalomyopathies? Approaches to therapy. Neurotherapeutics 2008;5:558-68. [PMID: 19019307 DOI: 10.1016/j.nurt.2008.07.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
194 Schmitz-Hübsch T, Klockgether T. An update on inherited ataxias. Curr Neurol Neurosci Rep 2008;8:310-9. [PMID: 18590615 DOI: 10.1007/s11910-008-0048-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
195 Bao X, Wu Y, Wong LC, Zhang Y, Xiong H, Chou P, Truong CK, Jiang Y, Qin J, Yuan Y, Lin Q, Wu X. Alpers syndrome with prominent white matter changes. Brain and Development 2008;30:295-300. [DOI: 10.1016/j.braindev.2007.08.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
196 Chan SSL. Inherited mitochondrial genomic instability and chemical exposures. Toxicology 2017;391:75-83. [PMID: 28756246 DOI: 10.1016/j.tox.2017.07.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]